The Biological Treatment of Paraphilic Disorders: an Updated Review
- 1.8k Downloads
Paraphilic disorders are characterized by atypical sexual interests, fantasies, and behaviors that are subjectively distressing to patients or pose a risk of harm to others. By their very nature, some paraphilic disorders may predispose an individual to commit sexual offenses. The biological treatment of paraphilic disorders, then, is of paramount importance for psychiatry and society at large. Three categories of pharmacologic agents commonly used to treat paraphilic disorders are selective serotonin reuptake inhibitors, synthetic steroidal analogs, and gonadotropin-releasing hormone analogs. Each medication uses a different mechanism of action and has different effects on the physiological and psychological features of paraphilic disorders. In general, these medications have limited high-quality research to support their use. Despite this, some authors have proposed treatment algorithms for individuals with paraphilic disorders of varying severity. These guidelines offer clinicians potentially useful, rational approaches to assessing treatment need in individuals with paraphilic disorders. Recent neuroimaging research suggests that functional magnetic resonance imaging may offer further promise in effectively assessing paraphilic disorders to help direct treatment options.
KeywordsParaphilic disorder Sexual offending Selective serotonin reuptake inhibitors Antiandrogen Gonadotropin-releasing hormone analogs Sexual deviancy
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Krafft-Ebing RV. Psychopathia sexualis. 12th ed. New York: Pioneer Publications; 1950.Google Scholar
- 2.Laws DR, O’Donohue WT. Sexual deviance: theory, assessment, and treatment. 2nd ed. New York: Guilford Press; 2008.Google Scholar
- 4.••Dennis JA. Psychological interventions for adults who have sexually offended or are at risk of offending. Cochrane Database Syst Rev. 2012;12:CD007507. This important Cochrane review evaluated evidence from studies on psychological interventions for adults who sexually offend. They found no difference between treated and untreated groups in terms of the risk of reoffending, as measured by a new sexual crime conviction. They concluded that more research is needed. PubMedGoogle Scholar
- 5.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association; 2013.Google Scholar
- 6.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text rev. Washington: American Psychiatric Association; 2000.Google Scholar
- 7.••American Psychiatric Association (2013). Paraphilic Disorders Fact Sheet. Available at: http://www.dsm5.org/Documents/Paraphilic%20Disorders%20Fact%20Sheet.pdf. This resource document from the American Psychiatric Association summarizes the changes made in the paraphilic diagnoses between DSM-IV-TR and DSM-5 . It also explains the Sexual and Gender Identity Disorders Work Group’s rationale for these changes.
- 13.•Bijlsma EY et al. Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release? Pharmacol Biochem Behav. 2014;121:88–101. The authors review the pharmacologic basis of the sexual side effects of selective serotonin reuptake inhibitors (SSRIs). They note that increasing dopamine neurotransmission overcomes the sexual side effects of SSRIs. They therefore hypothesize that the sexual side effects of SSRIs result from the inhibition of dopamine neurotransmission in sex brain circuits. CrossRefPubMedGoogle Scholar
- 19.Bradford J, Federoff JP. Pharmacological treatment of the juvenile sex offender. In: Barbaree HE, Marshall WL, editors. The juvenile sex offender. New York: Guilford Press; 2006. p. 358–82.Google Scholar
- 24.Craissati J. Managing high risk sex offenders in the community: a psychological approach. New York: Routledge; 2004.Google Scholar
- 29.••Khan O et al. Pharmacological interventions for those who have sexually offended or are at risk of offending. Cochrane Database Syst Rev. 2015;2:CD007989. This Cochrane review summarizes current available research on the utility of pharmacologic treatments in sexual offenders. It highlights the paucity of high-quality research in this area. PubMedGoogle Scholar
- 32.Meyer JW, Cole CM. Physical and chemical castration of sex offenders: a review. J Offender Rehabil. 1997;25(3–4):1–18.Google Scholar
- 44.••Cheng JC et al. Neuroimaging and sexual behavior: identification of regional and functional differences. Curr Psychiatry Rep. 2015;17:55. The authors summarize neuroimaging findings in sexual behavior and their relevance in sexual disorders including pedophilic disorder and compulsive sexual behavior. Google Scholar
- 45.••Wiebking C, Northoff G. Neuroimaging in pedophilia. Curr Psychiatry Rep. 2013;15(4):351. The authors provide a comprehensive summary of the use of neuroimaging in the assessment of pedophilic disorder. In addition, they discuss the potential use of neurofeedback to augment treatment of pedophilic disorder. CrossRefPubMedGoogle Scholar
- 47.••Kärgel C et al. Diminished functional connectivity on the road to child sexual abuse in pedophilia. J Sex Med. 2015;12(3):783–95. The authors identified differences in the functional connectivity at rest (a measure of resting neural activity) between pedophiles who had committed child sexual abuse and those who had not. This suggests that fMRI may assist in identifying pedophilic individuals who are at a higher risk of engaging in sexual crimes. CrossRefPubMedGoogle Scholar